首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1654666

全球角膜移植市場 - 2025 - 2033

Global Corneal Transplant Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球角膜移植市場規模達到 5.2388 億美元，預計到 2033 年將達到 10069.5 億美元，2025-2033 年預測期內的複合年成長率為 7.59%。

角膜移植，也稱為角膜移植術，是一種外科手術，用捐贈的角膜替換受損或患病的角膜，以恢復視力並改善眼睛健康。角膜是眼睛前部的透明圓頂狀層，它的健康對於正常視力至關重要。當圓錐角膜、角膜營養不良、角膜瘢痕和感染等情況導致嚴重視力障礙或失明時，通常會進行角膜移植。根據角膜損傷的程度，此手術可以涉及全層移植（穿透性角膜移植）或部分層移植（板層角膜移植）。

雷射輔助和微創手術等手術技術的進步顯著改善了角膜移植的效果，縮短了恢復時間並提高了移植存活率。

市場動態：

促進因素與約束因素

角膜疾病和眼部疾病數量不斷增加

角膜疾病和眼部疾病的數量不斷增加是推動角膜移植需求的主要因素。圓錐角膜、角膜營養不良、感染和疤痕等病症變得越來越常見，這增加了透過移植來恢復視力的需求。例如，根據美國國立衛生研究院 2022 年的數據，圓錐角膜影響了中東等少數地區約 5% 的人口。

這些情況會導致嚴重的視力問題甚至失明，迫使許多患者尋求角膜移植作為解決方案。這些疾病的發生率在年輕人中尤其明顯，圓錐角膜等疾病影響著許多十幾歲或二十幾歲的年輕人。

由於多種因素，全球範圍內角膜移植的發生率不斷增加。隨著這種成長，各機構和診所正在執行這些程序以滿足不斷成長的需求。例如，過去35年來，LVPEI（LV普拉薩德眼科研究所）已成功取得了超過120,000個角膜，成為亞太地區最大的角膜捐贈計畫。目前，該研究所每年可摘取超過12,000枚角膜，為提供可供移植的捐贈角膜做出了重大貢獻。預計這些程序的增加將增加對手術所需設備和套件的需求，從而進一步促進市場的成長。

角膜移植相關併發症

與角膜移植相關的併發症和風險可能會使患者和醫療專業人員感到沮喪，從而阻礙市場的成長。雖然角膜移植通常是成功的，但仍有諸如移植排斥、感染和角膜腫脹等潛在問題，可能導致移植失敗。這些問題可能需要額外的手術或長期用藥來防止排斥，從而使恢復過程複雜化，這可能會導致移植的採用速度變慢並影響市場的擴張。

CorneaGen
Ziemer Ophthalmic Systems AG
RUMEX International Co.
CorNeat Vision
KeraMed, Inc.
Corza Ophthalmology
Inami & CO.,Ltd
Leica Microsystems
Surtex Instruments Limited.
Similar data will be provided for each market player.
Processa 製藥公司
- 管道產品描述
- 產品關鍵績效指標 (KPI)
- 主要活動
- 市場進入時間表
- 產品滲透率
- 銷售估計和預測
Vanda 製藥公司
Renexxion 愛爾蘭有限公司
Aclipse治療公司
將為每個市場參與者提供類似的資料。

第 15 章：附錄

簡介目錄

Product Code: PH9100

The global corneal transplant market reached US$ 523.88 million in 2024 and is expected to reach US$ 1,006.95 billion by 2033, growing at a CAGR of 7.59% during the forecast period 2025-2033.

Corneal transplant, also known as keratoplasty, is a surgical procedure in which a damaged or diseased cornea is replaced with a donor cornea to restore vision and improve eye health. The cornea is the transparent, dome-shaped layer at the front of the eye, and its health is crucial for proper vision. Corneal transplants are typically performed when conditions such as keratoconus, corneal dystrophies, corneal scarring, and infection lead to significant vision impairment or blindness. The procedure can involve either full-thickness transplants (penetrating keratoplasty) or partial-thickness transplants (lamellar keratoplasty), depending on the extent of the corneal damage.

Advancements in surgical techniques, such as laser-assisted and minimally invasive procedures, have significantly improved the outcomes of corneal transplants, reducing recovery times and increasing graft survival rates.

Market Dynamics: Drivers & Restraints

Growing number of corneal diseases and eye disorders

The growing number of corneal diseases and eye disorders is a major factor driving the demand for Corneal Transplants. Conditions like keratoconus, corneal dystrophies, infections, and scarring are becoming more common, which is increasing the need for transplants as a way to restore vision. For instance, according to the National Institute of Health in 2022, keratoconus affects about 5% of the population in few regions, Middle East.

These conditions can cause serious vision problems and even blindness, pushing many patients to seek corneal transplants as a solution. The rise in these disorders is particularly noticeable among younger people, with conditions like keratoconus affecting many in their teens or twenties.

There is a growing incidnce of corneal transplantations across the globe due to several factors. With this growth, the institutes and clinics are performing these procedures to meet the rising demand. For instance, Over the past 35 years, LVPEI (L V Prasad Eye Institute) has successfully harvested more than 120,000 corneas, making it the largest corneal donation program in the Asia-Pacific region. Currently, the institute is able to harvest over 12,000 corneas annually, contributing significantly to the availability of donor corneas for transplantation. This increasing procedures is expected to increase the demand for the devices and kits required for performing, further contributing to the growing market.

Complications associated with corneal transplantation

Complications and risks associated with Corneal Transplants could hold back the market's growth by discouraging both patients and healthcare professionals. Although corneal transplants are generally successful, there are still potential issues like graft rejection, infections, and corneal swelling that could cause the transplant to fail. These problems might require extra surgeries or long-term medication to prevent rejection, complicating the recovery process, which may lead to slower adoption of transplants and impact the market's expansion.

Segment Analysis

The global corneal transplant market is segmented based on procedure type, device type, surgery type, indication, end-user, and region.

Treatment:

Microsurgical instruments segment is expected to dominate the global corneal transplant market share

The microsurgical instruments segment is expected to hold a dominant position in the corneal transplant market due to the significant role these specialized tools play in the success of corneal transplant surgeries. Corneal transplant procedures are highly delicate and require precise, minimally invasive techniques to ensure proper graft placement and reduce the risk of complications. Microsurgical instruments, such as fine forceps, micro scissors, and laser-assisted tools, allow surgeons to perform these intricate surgeries with exceptional precision and control.

As advancements in surgical techniques continue, microsurgical instruments are becoming more sophisticated, improving outcomes, and reducing recovery times for patients. This advanced features are creating a high demand for these devices. Several market players are increasing developing advanced m,icrosurgical instruments to perform penetrating keratoplasty (full-thickness transplants) and lamellar keratoplasty (partial-thickness transplants), which require extremely fine and accurate cuts to minimize tissue damage and enhance graft survival.

With the increasing number of corneal transplants being performed globally, the demand for advanced microsurgical instruments is growing, as they are integral to ensuring the safety and success of these procedures.

Geographical Analysis

North America is expected to hold a significant position in the global corneal transplant market share

North America is expected to maintain a leading position in the global corneal transplant market for several key reasons. The region's advanced healthcare infrastructure, high awareness of eye health, and access to cutting-edge medical technologies all play a major role. Both the United States and Canada have well-established healthcare systems with top-tier medical facilities and highly skilled ophthalmologists, making them leaders in performing complex corneal transplants. This expertise ensures high success rates, making North America a go-to destination for corneal transplants.

The growing prevalence of corneal diseases like keratoconus and corneal dystrophies, along with an aging population more prone to eye conditions, is also driving demand for corneal transplants in the region. For instance, according to the publication by the National Institute of Health in 2024, in the United States, the estimated prevalence of Fuchs' Endothelial Corneal Dystrophy (FECD) among individuals over the age of 65 is 1.12%. The condition is notably more common in women and the White population compared to other ethnic groups.

Moreover, continuous advancements in surgical techniques as well as innovations in artificial corneas and stem cell therapies, are strengthening North America's position in the market. For instance, in June 2024, CorneaGen launched Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes.

The region's ongoing investment in research and development in ophthalmology continues to improve transplant outcomes, reducing recovery times and increasing success rates. These factors all contribute to North America's dominant role in the global corneal transplant market.

Competitive Landscape

The major global players in the corneal transplant market include Carl Zeiss AG, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., CorNeat Vision, KeraMed, Inc., Corza Ophthalmology, Inami & CO., Ltd, Leica Microsystems and Surtex Instruments Limited. among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Corneal Transplant Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Procedure Type
3.2. Snippet by Device Type
3.3. Snippet by Type
3.4. Snippet by Surgery Type
3.5. Snippet by Indication
3.6. Snippet by End-User
3.7. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing number of corneal diseases and eye disorders
- 4.1.2. Restraints
  - 4.1.2.1. Complications associated with the corneal transplantation
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Procedure Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 6.1.2. Market Attractiveness Index, By Procedure Type
6.2. Endothelial Keratoplasty*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Penetrating Keratoplasty
6.4. Anterior Lamellar Keratoplasty (ALK)
6.5. Corneal Limbal Stem Cell Transplant
6.6. Artificial Corneal Transplant
6.7. Others

7. By Device Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 7.1.2. Market Attractiveness Index, By Device Type
7.2. Microsurgical Instruments*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Microkeratome
7.4. Optical Coherence Tomography (OCT)
7.5. Artificial Corneas
7.6. Others

8. By Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2. Market Attractiveness Index, By Type
8.2. Human Cornea*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Synthetic

9. By Surgery Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 9.1.2. Market Attractiveness Index, By Surgery Type
9.2. Conventional Surgery*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Laser-Assisted Surgery

10. By Indication

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 10.1.2. Market Attractiveness Index, By Indication
10.2. Fuch's Endothelial Dystrophy*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Infectious Keratitis
10.4. Bullous Keratopathy
10.5. Keratoconus
10.6. Regraft Procedures
10.7. Corneal Scarring
10.8. Corneal Ulcers
10.9. Others

11. By End-User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ophthalmic Clinics
11.4. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.9.1. U.S.
  - 12.2.9.2. Canada
  - 12.2.9.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.9.1. Germany
  - 12.3.9.2. U.K.
  - 12.3.9.3. France
  - 12.3.9.4. Spain
  - 12.3.9.5. Italy
  - 12.3.9.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.9.1. Brazil
  - 12.4.9.2. Argentina
  - 12.4.9.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.9.1. China
  - 12.5.9.2. India
  - 12.5.9.3. Japan
  - 12.5.9.4. South Korea
  - 12.5.9.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgery Type
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

Key Market Players

14.1. Carl Zeiss AG*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio
  - 14.1.2.1. Product Description
  - 14.1.2.2. Product Key Performance Indicators (KPIs)
  - 14.1.2.3. Historic and Forecasted Product Sales
  - 14.1.2.4. Product Sales Volume
- 14.1.3. Financial Overview
  - 14.1.3.1. Company Revenue's
  - 14.1.3.2. Geographical Revenue Shares
  - 14.1.3.3. Revenue Forecasts
- 14.1.4. Key Developments
  - 14.1.4.1. Mergers & Acquisitions
  - 14.1.4.2. Key Product Development Activities
  - 14.1.4.3. Regulatory Approvals etc.
- 14.1.5. SWOT Analysis
14.2. CorneaGen
14.3. Ziemer Ophthalmic Systems AG
14.4. RUMEX International Co.
14.5. CorNeat Vision
14.6. KeraMed, Inc.
14.7. Corza Ophthalmology
14.8. Inami & CO.,Ltd
14.9. Leica Microsystems
14.10. Surtex Instruments Limited.
Similar data will be provided for each market player.

Emerging Market Players

14.11. Processa Pharmaceuticals, Inc.*
- 14.11.1. Pipeline Products Description
- 14.11.2. Product Key Performance Indicators (KPIs)
- 14.11.3. Key Activities
- 14.11.4. Market Entry Timelines
- 14.11.5. Product Penetration Rate
- 14.11.6. Sales Estimation and Projections
14.12. Vanda Pharmaceuticals Inc.
14.13. Renexxion Ireland Limited
14.14. Aclipse Therapeutics
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE